Ken Griffin Neuroone Medical Technologies Corp Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 69,600 shares of NMTC stock, worth $62,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,600
Previous 40,800 70.59%
Holding current value
$62,640
Previous $33,000 78.79%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$0.83 - $1.22 $59,506 - $87,467
-71,695 Reduced 87.64%
10,107 $8,000
Q4 2024

Feb 14, 2025
BUY
$0.59 - $1.01 $48,263 - $82,620
81,802 New
81,802 $67,000
Q4 2022

Feb 14, 2023
BUY
$0.84 - $2.82 $30,322 - $101,796
36,098 New
36,098 $43,000

About NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Quotes by TradingView
  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $14.6M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email